Literature DB >> 1086780

Effects of levamisole on spontaneous rosette-forming cells in murine spleen.

R F van Ginckel, J Hoebeke.   

Abstract

Levamisole, an anti-anergic chemotherapeutic agent, is shown to depress the azathioprine sensitivity of rosette-forming cells (RFC) in the spleen of normal mice, and to restore the azathioprine sensitivity of RFC in the spleen of adult thymectomized mice. Using the fully active dose of 1.25 mg/kg i.v., the restoration effect was present 15 h after treatment with the drug and almost disappeared after 48 h. Levamisole was ineffective on RFC in vitro. These results suggest that Levamisole might interfere with the reactivity of T lymphocytes as has been described for drugs interfering with cyclic nucleotide metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086780     DOI: 10.1002/eji.1830060414

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.

Authors:  H Verhaegen; W De Cock; J De Cree
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  New approaches to immunotherapy: thymomimetic drugs.

Authors:  S Specter; J W Hadden
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Effect of levamisole on autologous rosette-forming cells in nude mice.

Authors:  J Van Wauwe; G Van Nijen
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

4.  Thymopoietin and levamisole in chronic granulomatous inflammation.

Authors:  P A Thrower; A D Sedgwick; E R Smith; D A Willoughby; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

5.  Levamisole and human lymphocyte surface markers.

Authors:  J Wybran; A Govaerts
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

6.  The effects of azathioprine and levamisole on lymphocyte stimulation.

Authors:  L Ivanyi
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.